Results 201 to 210 of about 21,165 (234)

Curcumin-Piperine Self-Nanoemulsifying Delivery in <i>Zanthoxylum rhetsa</i> Seed Oil Attenuates Cuprizone-Induced Frontal Cortex Toxicity. [PDF]

open access: yesPharmaceuticals (Basel)
Alam MZ   +14 more
europepmc   +1 more source

Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter

open access: yes
Brechbühl EE   +9 more
europepmc   +1 more source

REMYELINATION IN MULTIPLE SCLEROSIS

Journal of Neuropathology and Experimental Neurology, 1978
AbstractChronic plaques in central nervous system tissue fixed by in situe perfusion for electron microscopy were examined for evidence of remyelination in 2 patients with multiple sclerosis (MS). Fibers with abnormal central myelin sheaths of several types were found at the margins of most of the plaques studied. The most common of these were: (1) the
J W, Prineas, F, Connell
openaire   +2 more sources

Ageing and CNS remyelination

NeuroReport, 2002
Remyelination of demyelinated axons in the CNS is a regenerative process that, like many others, becomes less efficient with age. This article reviews a series of studies in which toxin models of demyelination have been used to characterize this phenomenon.
Robin J M, Franklin   +2 more
openaire   +2 more sources

Macrophages and CNS remyelination

Journal of Neurochemistry, 2014
AbstractMicroglia are the resident macrophages of the central nervous system that survey the microenvironment for signals of injury or infection. The response to such signals induces an inflammatory response involving macrophages derived from both resident microglia and recruited circulating monocytes.
Veronique E, Miron, Robin J M, Franklin
openaire   +2 more sources

TREM2 activation promotes remyelination

Nature Reviews Neurology, 2020
Cignarella, F. et al. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol. https://doi.org/10.1007/s00401-020-02193-z (2020) Article PubMed Google Scholar Ulland, T. K. & Colonna, M. TREM2 — a key player in microglial biology and Alzheimer disease. Nat. Rev. Neurol. 14, 667–
openaire   +2 more sources

Remyelination in multiple sclerosis

Multiple Sclerosis Journal, 1997
Stimulation of remyelination in multiple sclerosis lesions may be one possible therapeutic approach. However, since the pathology and pathogenesis of multiple sclerosis may be heterogeneous, it is important to analyze in what patients and at what stages of the disease such a therapy can be reasonable and feasible.
H, Lassmann   +3 more
openaire   +2 more sources

Imaging of remyelination

Multiple Sclerosis Journal, 1997
Now that the concept of remyelination is gaining acceptance in MS, there is a need for a paraclinical marker to monitor remyelination in MS, for example to study the effect of therapeutical interventions. At present there is no known imaging marker for remyelination.
openaire   +2 more sources

Remyelination in multiple sclerosis

2009
Remyelination in multiple sclerosis is in most cases insufficient, leading to irreversible disability. Different and nonexclusive factors account for this repair deficit. Local inhibitors of the differentiation of oligodendrocyte progenitor cells (OPCs) might play a role, as well as axonal factors impairing the wrapping process. Alternatively, a defect
Gabrièle, Piaton   +3 more
openaire   +2 more sources

Remyelination during optic nerve compression

Journal of the Neurological Sciences, 1980
The structural changes produced in cat optic nerve by incremental chronic compression have been investigated by light and electron microscopy. Within the first week extensive demyelination occurred; some fibres underwent Wallerian degeneration and there was marked proliferation of astrocytic processes.
R E, Clifford-Jones   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy